Literature DB >> 23192592

Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis.

Yajarayma J Tang-Feldman1, Stephanie R Lochhead, G Raymond Lochhead, Cindy Yu, Michael George, Amparo C Villablanca, Claire Pomeroy.   

Abstract

Multiple studies suggest an association between cytomegalovirus (CMV) infection and atherogenesis; however, the molecular mechanisms by which viral infection might exacerbate atherosclerosis are not well understood. Aortas of MCMV-infected and uninfected Apo E knockout (KO) mice were analyzed for atherosclerotic lesion development and differential gene expression. Lesions in the infected mice were larger and showed more advanced disease compared to the uninfected mice. Sixty percent of the genes in the MAPK pathway were upregulated in the infected mice. p38 and ERK 1/2 MAPK genes were 5.6- and 2.0-fold higher, respectively, in aortas of infected vs. uninfected mice. Levels of VCAM-1, ICAM-1, and MCP-1 were ~2.0-2.6-fold higher in aortas of infected vs. uninfected mice. Inhibition of p38 with SB203580 resulted in lower levels of pro-atherogenic molecules and MCMV viral load in aortas of infected mice. MCMV-induced upregulation of p38 may drive the virus-induced acceleration of atherogenesis observed in our model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192592      PMCID: PMC4591060          DOI: 10.1007/s12265-012-9428-x

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  40 in total

1.  The role of MKK1/2 kinase activity in human cytomegalovirus infection.

Authors:  Robert A Johnson; Xiu-Li Ma; Andrew D Yurochko; Eng-Shang Huang
Journal:  J Gen Virol       Date:  2001-03       Impact factor: 3.891

Review 2.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection.

Authors:  S C Henry; K Schmader; T T Brown; S E Miller; D N Howell; G G Daley; J D Hamilton
Journal:  J Virol Methods       Date:  2000-09       Impact factor: 2.014

4.  Impact of infectious burden on progression of carotid atherosclerosis.

Authors:  Christine Espinola-Klein; Hans-Jürgen Rupprecht; Stefan Blankenberg; Christoph Bickel; Helmuth Kopp; Anja Victor; Gerd Hafner; Wilfried Prellwitz; Wolfgang Schlumberger; Jürgen Meyer
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

5.  Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.

Authors:  R A Johnson; S M Huong; E S Huang
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction.

Authors:  Igor L Leskov; Jennifer Whitsett; Jeannette Vasquez-Vivar; Karen Y Stokes
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

7.  The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment.

Authors:  V Marin; C Farnarier; S Grès; S Kaplanski; M S Su; C A Dinarello; G Kaplanski
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

8.  Cytokine mRNA levels in isolated feline monocytes.

Authors:  A Kipar; C M Leutenegger; U Hetzel; M K Akens; C N Mislin; M Reinacher; H Lutz
Journal:  Vet Immunol Immunopathol       Date:  2001-02-10       Impact factor: 2.046

9.  Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice.

Authors:  E Hsich; Y F Zhou; B Paigen; T M Johnson; M S Burnett; S E Epstein
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

10.  MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice.

Authors:  Inge Vliegen; Frank Stassen; Gert Grauls; Rien Blok; Catrien Bruggeman
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

View more
  13 in total

Review 1.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

Review 2.  Novel Strategies to Combat CMV-Related Cardiovascular Disease.

Authors:  Elena Vasilieva; Sara Gianella; Michael L Freeman
Journal:  Pathog Immun       Date:  2020-09-20

3.  Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway.

Authors:  Lulu Pan; Yuanhai Zhang; Jiacheng Lu; Zhimin Geng; Lianhong Jia; Xing Rong; Zhenquan Wang; Qifeng Zhao; Rongzhou Wu; Maoping Chu; Chunxiang Zhang
Journal:  J Cardiovasc Transl Res       Date:  2015-11-02       Impact factor: 4.132

Review 4.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021

5.  Impact of hepatitis C seropositivity on the risk of coronary heart disease events.

Authors:  Naga Venkata Krishna Chand Pothineni; Robert Delongchamp; Srikanth Vallurupalli; Zufeng Ding; Yao Dai; Curt H Hagedorn; Jawahar L Mehta
Journal:  Am J Cardiol       Date:  2014-09-28       Impact factor: 2.778

Review 6.  Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.

Authors:  Jalaj Gupta; Angel R Nebreda
Journal:  FEBS J       Date:  2015-03-16       Impact factor: 5.542

Review 7.  Human cytomegalovirus infection and coronary heart disease: a systematic review.

Authors:  Yu Du; Guangxue Zhang; Zhijun Liu
Journal:  Virol J       Date:  2018-02-06       Impact factor: 4.099

Review 8.  Competitive virus and host RNAs: the interplay of a hidden virus and host interaction.

Authors:  Changfei Li; Jun Hu; Junli Hao; Bao Zhao; Bo Wu; Lu Sun; Shanxin Peng; George F Gao; Songdong Meng
Journal:  Protein Cell       Date:  2014-04-12       Impact factor: 14.870

9.  The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.

Authors:  Yanmei Zeng; Chenzhong Li; Meiping Guan; Zongji Zheng; Jingjing Li; Wenwei Xu; Ling Wang; Feiying He; Yaoming Xue
Journal:  Cardiovasc Diabetol       Date:  2014-02-04       Impact factor: 9.951

10.  Sitagliptin attenuates high glucose-induced alterations in migration, proliferation, calcification and apoptosis of vascular smooth muscle cells through ERK1/2 signal pathway.

Authors:  Lili Shi; Ye Ji; Dandan Liu; Ying Liu; Ying Xu; Yang Cao; Xiaoyan Jiang; Changqing Xu
Journal:  Oncotarget       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.